Nathan Rich
Stock Analyst at Goldman Sachs
(0.99)
# 3,872
Out of 5,044 analysts
84
Total ratings
35.48%
Success rate
-10.16%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $19.67 | +6.76% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $147.53 | +32.85% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $13.09 | +129.18% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $10.25 | -21.95% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $20.35 | -14.00% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $292.34 | +31.70% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $22.27 | -37.14% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $19.61 | -43.91% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $135.65 | +65.87% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $647.40 | +0.40% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $82.45 | +6.73% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $17.77 | -32.47% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $63.54 | +33.77% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $10.42 | +5.57% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $162.19 | +106.55% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $365.98 | +46.18% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $19.67
Upside: +6.76%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $147.53
Upside: +32.85%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $13.09
Upside: +129.18%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $10.25
Upside: -21.95%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $20.35
Upside: -14.00%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $292.34
Upside: +31.70%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $22.27
Upside: -37.14%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $19.61
Upside: -43.91%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $135.65
Upside: +65.87%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $647.40
Upside: +0.40%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $82.45
Upside: +6.73%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $17.77
Upside: -32.47%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $63.54
Upside: +33.77%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $10.42
Upside: +5.57%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $162.19
Upside: +106.55%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $365.98
Upside: +46.18%